Engineered blood and lymphatic capillaries in 3‐D VEGF‐fibrin‐collagen matrices with interstitial flow

In vitro endothelial cell organization into capillaries is a long standing challenge of tissue engineering. We recently showed the utility of low level interstitial flow in guiding the organization of endothelial cells through a 3‐D fibrin matrix‐containing covalently bound vascular endothelial growth factor (VEGF). Here this synergistic phenomenon was extended to explore the effects of matrix composition on in vitro capillary morphogenesis of human blood versus lymphatic endothelial cells (BECs and LECs). Different mixtures of fibrin and collagen were used in conjunction with constant concentrations of matrix‐bound VEGF and slow interstitial flow over 10 days. Interestingly, the BECs and LECs each showed a distinct preference in terms of organization for matrix composition: LECs organized the most extensively in a fibrin‐only matrix, while BEC organization was optimized in the compliant collagen‐containing matrices. Furthermore, the BECs and LECs produced architecturally different structures; while BECs organized in thick, branched networks containing wide lumen, the LECs were elongated into slender, overlapping networks with fine lumen. These data demonstrate the importance of the 3‐D matrix composition in facilitating and coordinating BEC and LEC capillary morphogenesis, which is important for in vitro vascularization of engineered tissues. Biotechnol. Bioeng. 2007;96: 167–176. © 2006 Wiley Periodicals, Inc.

[1]  B. Kudryk,et al.  Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. , 1999, Biochemistry.

[2]  M. Neeman,et al.  Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. , 2002, Cancer research.

[3]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 , 2004 .

[4]  M. Swartz,et al.  Characterization of lymphangiogenesis in a model of adult skin regeneration. , 2006, American journal of physiology. Heart and circulatory physiology.

[5]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[6]  G. Laurent,et al.  Fibrinogen , 1968, Reactions Weekly.

[7]  S. Albelda,et al.  Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. , 1989, The Journal of clinical investigation.

[8]  Léone Tranqui,et al.  The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors , 2004, Angiogenesis.

[9]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. , 2004, Microvascular research.

[10]  J. A. Sjøland A new optimized method for the determination of fibrin clot permeability , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  Kayla J Bayless,et al.  Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices , 2002, The Anatomical record.

[12]  C. Jackson,et al.  Human endothelial gelatinases and angiogenesis. , 2001, The international journal of biochemistry & cell biology.

[13]  Jeffrey A. Hubbell,et al.  Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth , 2004, Circulation research.

[14]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[15]  Melody A. Swartz,et al.  Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro , 2005, Journal of Cell Science.

[16]  R. Clark,et al.  Fibrin and Collagen Differentially Regulate Human Dermal Microvascular Endothelial Cell Integrins: Stabilization of αv/β3 mRNA by Fibrin1 , 1999 .

[17]  P. Koolwijk,et al.  Role of Fibrin Matrix in Angiogenesis , 2001, Annals of the New York Academy of Sciences.

[18]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[19]  Martin Ehrbar,et al.  Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  D. Kohane,et al.  Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.

[21]  Melody A. Swartz,et al.  Interstitial Flow as a Guide for Lymphangiogenesis , 2003, Circulation research.

[22]  Lucie Germain,et al.  In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  J. Hubbell,et al.  Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[24]  N. Skelton,et al.  Heparin-binding Domain from Vascular Endothelial Growth Factor , 2002 .

[25]  R K Jain,et al.  Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[27]  John A. Pedersen,et al.  Mechanobiology in the Third Dimension , 2005, Annals of Biomedical Engineering.

[28]  J. Hubbell,et al.  Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. , 2005, Biomaterials.

[29]  M. P. Welch,et al.  Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. , 1995, Journal of cell science.

[30]  M. Swartz,et al.  Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. , 2003, American journal of physiology. Heart and circulatory physiology.

[31]  M. Gerritsen,et al.  Lumen Formation In Vivo Versus In Vitro Observations , 2003, Microcirculation.

[32]  M. Pepper Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[33]  V. Nehls,et al.  The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. , 1996, Microvascular research.

[34]  W A Morrison,et al.  Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. , 2002, British journal of plastic surgery.

[35]  Melody A Swartz,et al.  Autologous morphogen gradients by subtle interstitial flow and matrix interactions. , 2006, Biophysical journal.

[36]  Milan Mrksich,et al.  Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates , 1999, In Vitro Cellular & Developmental Biology - Animal.

[37]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[38]  Lucie Germain,et al.  Inosculation of Tissue‐Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[39]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[40]  R. Clark,et al.  Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3 mRNA by fibrin1. , 1999, The Journal of investigative dermatology.

[41]  D. Vittet,et al.  In Vitro Models of Vasculogenesis and Angiogenesis , 2001, Laboratory Investigation.

[42]  M. Nugent,et al.  Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. , 2000, Biochemistry.

[43]  H. Hammes,et al.  Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  M. Skobe,et al.  Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Martin Ehrbar,et al.  Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Federica Boschetti,et al.  Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Orci,et al.  Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. , 1996, Enzyme & protein.

[48]  B. Keyt,et al.  Solution structure of the heparin-binding domain of vascular endothelial growth factor. , 1998, Structure.

[49]  Melody A Swartz,et al.  Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. , 2004, Microvascular research.

[50]  Dai Fukumura,et al.  Engineering vascularized tissue , 2005, Nature Biotechnology.

[51]  O Damour,et al.  A tissue‐engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary‐like tube formation in vitro , 2003, The British journal of dermatology.

[52]  L. Lorand,et al.  Structural origins of fibrin clot rheology. , 1999, Biophysical journal.

[53]  S. Chien,et al.  Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Hubbell,et al.  Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. , 1998, Journal of biomedical materials research.

[55]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[56]  T. Haas Endothelial cell regulation of matrix metalloproteinases. , 2005, Canadian journal of physiology and pharmacology.